FIELD: medicine, cardiology.
SUBSTANCE: one should introduce the suspension of autologous mononuclear medullary cells without preliminary cultivation in to the mouth of coronary artery nourishing infarction area. Cell suspension should be introduced at the quantity of 100-150 mln. cells immediately after stenting coronary artery due to technique of passive passage. The procedure should be performed on the 14th - 21st d against the onset of the disease mentioned. The method provides efficient counterbalance of cardiomyocytes due to applying valuable stem cells at excluding complications induced by arterial occlusion.
EFFECT: higher efficiency of therapy.
1 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING PATIENTS WITH ISCHEMIC CARDIAC DISEASE AFTER MYOCARDIAL INFARCTION | 2005 |
|
RU2308982C2 |
| METHOD OF TREATMENT OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION WITH LATE HOSPITALIZATION | 2017 |
|
RU2661048C1 |
| METHOD FOR TREATING PATIENTS WITH THE DEFECTS OF CARDIAC VALVES | 2006 |
|
RU2311140C1 |
| METHOD OF CHRONIC CARDIAC INSUFFICIENCY MEDICAL TREATMENT | 2006 |
|
RU2325934C1 |
| METHOD FOR TREATING CHRONIC DISEASES (VARIANTS), METHOD FOR OBTAINING A BIOTRANSPLANT (VARIANTS), A BIOTRANSPLANT (VARIANTS) | 2006 |
|
RU2322248C2 |
| METHOD FOR TREATING THE CASES OF NON-OPERABLE CARDIOLOGIC PATIENTS | 2004 |
|
RU2250772C1 |
| METHOD TO EXTRACT STEM CELLS FROM BONE MARROW FOR INTRAVASCULAR INTRODUCTION | 2012 |
|
RU2496871C1 |
| METHOD OF TREATING CARDIOVASCULAR DISEASE | 2023 |
|
RU2822010C1 |
| BIOTRANSPLANT CONTAINING NUCLEUS-CONTAINING BONE MARROW CELLS INCLUDING PREDIFFERENTIATED IN ENDOTHELIAL AND CARDIOMYOCYTIC DIRECTION, METHOD FOR PRODUCING IT AND METHOD FOR TREATING CARDIAC INSUFFICIENCY CASES | 2006 |
|
RU2314816C2 |
| METHOD OF TREATING LOWER EXTREMITY ISCHEMIA | 2012 |
|
RU2546007C2 |
